Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.

Nucleophosmin (NPM) is a multifunctional nuclear phosphoprotein and a histone chaperone implicated in chromatin organization and transcription control. Oncogenic Kaposi's sarcoma herpesvirus (KSHV) is the etiological agent of Kaposi's sarcoma, primary effusion lymphoma (PEL) and multicentr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Grzegorz Sarek, Annika Järviluoma, Henna M Moore, Sari Tojkander, Salla Vartia, Peter Biberfeld, Marikki Laiho, Päivi M Ojala
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
Acceso en línea:https://doaj.org/article/fde858a70594489799a0ec0cfa14078d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fde858a70594489799a0ec0cfa14078d
record_format dspace
spelling oai:doaj.org-article:fde858a70594489799a0ec0cfa14078d2021-11-25T05:48:13ZNucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.1553-73661553-737410.1371/journal.ppat.1000818https://doaj.org/article/fde858a70594489799a0ec0cfa14078d2010-03-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20333249/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Nucleophosmin (NPM) is a multifunctional nuclear phosphoprotein and a histone chaperone implicated in chromatin organization and transcription control. Oncogenic Kaposi's sarcoma herpesvirus (KSHV) is the etiological agent of Kaposi's sarcoma, primary effusion lymphoma (PEL) and multicentric Castleman disease (MCD). In the infected host cell KSHV displays two modes of infection, the latency and productive viral replication phases, involving extensive viral DNA replication and gene expression. A sustained balance between latency and reactivation to the productive infection state is essential for viral persistence and KSHV pathogenesis. Our study demonstrates that the KSHV v-cyclin and cellular CDK6 kinase phosphorylate NPM on threonine 199 (Thr199) in de novo and naturally KSHV-infected cells and that NPM is phosphorylated to the same site in primary KS tumors. Furthermore, v-cyclin-mediated phosphorylation of NPM engages the interaction between NPM and the latency-associated nuclear antigen LANA, a KSHV-encoded repressor of viral lytic replication. Strikingly, depletion of NPM in PEL cells leads to viral reactivation, and production of new infectious virus particles. Moreover, the phosphorylation of NPM negatively correlates with the level of spontaneous viral reactivation in PEL cells. This work demonstrates that NPM is a critical regulator of KSHV latency via functional interactions with v-cyclin and LANA.Grzegorz SarekAnnika JärviluomaHenna M MooreSari TojkanderSalla VartiaPeter BiberfeldMarikki LaihoPäivi M OjalaPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 6, Iss 3, p e1000818 (2010)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Grzegorz Sarek
Annika Järviluoma
Henna M Moore
Sari Tojkander
Salla Vartia
Peter Biberfeld
Marikki Laiho
Päivi M Ojala
Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
description Nucleophosmin (NPM) is a multifunctional nuclear phosphoprotein and a histone chaperone implicated in chromatin organization and transcription control. Oncogenic Kaposi's sarcoma herpesvirus (KSHV) is the etiological agent of Kaposi's sarcoma, primary effusion lymphoma (PEL) and multicentric Castleman disease (MCD). In the infected host cell KSHV displays two modes of infection, the latency and productive viral replication phases, involving extensive viral DNA replication and gene expression. A sustained balance between latency and reactivation to the productive infection state is essential for viral persistence and KSHV pathogenesis. Our study demonstrates that the KSHV v-cyclin and cellular CDK6 kinase phosphorylate NPM on threonine 199 (Thr199) in de novo and naturally KSHV-infected cells and that NPM is phosphorylated to the same site in primary KS tumors. Furthermore, v-cyclin-mediated phosphorylation of NPM engages the interaction between NPM and the latency-associated nuclear antigen LANA, a KSHV-encoded repressor of viral lytic replication. Strikingly, depletion of NPM in PEL cells leads to viral reactivation, and production of new infectious virus particles. Moreover, the phosphorylation of NPM negatively correlates with the level of spontaneous viral reactivation in PEL cells. This work demonstrates that NPM is a critical regulator of KSHV latency via functional interactions with v-cyclin and LANA.
format article
author Grzegorz Sarek
Annika Järviluoma
Henna M Moore
Sari Tojkander
Salla Vartia
Peter Biberfeld
Marikki Laiho
Päivi M Ojala
author_facet Grzegorz Sarek
Annika Järviluoma
Henna M Moore
Sari Tojkander
Salla Vartia
Peter Biberfeld
Marikki Laiho
Päivi M Ojala
author_sort Grzegorz Sarek
title Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
title_short Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
title_full Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
title_fullStr Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
title_full_unstemmed Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
title_sort nucleophosmin phosphorylation by v-cyclin-cdk6 controls kshv latency.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/fde858a70594489799a0ec0cfa14078d
work_keys_str_mv AT grzegorzsarek nucleophosminphosphorylationbyvcyclincdk6controlskshvlatency
AT annikajarviluoma nucleophosminphosphorylationbyvcyclincdk6controlskshvlatency
AT hennammoore nucleophosminphosphorylationbyvcyclincdk6controlskshvlatency
AT saritojkander nucleophosminphosphorylationbyvcyclincdk6controlskshvlatency
AT sallavartia nucleophosminphosphorylationbyvcyclincdk6controlskshvlatency
AT peterbiberfeld nucleophosminphosphorylationbyvcyclincdk6controlskshvlatency
AT marikkilaiho nucleophosminphosphorylationbyvcyclincdk6controlskshvlatency
AT paivimojala nucleophosminphosphorylationbyvcyclincdk6controlskshvlatency
_version_ 1718414497820966912